These publications were authored or co-authored by Quest Diagnostics staff.
Quantitative measurement of HER2 expression in breast cancers: comparison with 'real-world' routine HER2 testing in a multicenter Collaborative Biomarker Study and correlation with overall survival.Quest Diagnostics Authors: Pesano, RL
Authors: Yardley DA, Kaufman PA, Huang W, Krekow L, Savin M, Lawler WE, Zrada S, Starr A, Einhorn H, Schwartzberg LS, Adams JW, Lie Y, Paquet AC, Sperinde J, Haddad M, Anderson S, Brigino M, Pesano R, Bates MP, Weidler J, Bosserman L
Breast Cancer Res 2015;17:41
Genome-wide meta-analysis identifies multiple novel associations and ethnic heterogeneity of psoriasis susceptibility.Quest Diagnostics Authors: Catanese, J, Li, Y
Authors: Yin X, Low HQ, Wang L, Ellinghaus E, Han J, Estivill X, Sun L, Padyukov L, Krueger GG, Duffin KC, Mucha S, Weichenthal M, Weidinger S, Lieb W, Foo JN, Sim K, Liany H, Irwan I, Teo Y, Theng CT, Gupta R, Bowcock A, De Jager PL, Qureshi AA, de Bakker PI, Se
Nat Commun 2015;6:6916
Authors: Yu Y, Sikorski P, Cacciabeve N, Nelson KE, Pieper R
J Transl Med 2015;13:111
Reduced Expression of RECK Protein May Help Differentiate Cutaneous Malignant Melanoma from Melanocytic Nevus.Quest Diagnostics Authors: Junkins-Hopkins, J
Authors: Zhang L, Xie Q, Shan SJ, Tabor MK
Anticancer Res 2015;35:3185-3191
Low-Density Lipoprotein Particle Number Is Associated With Cardiovascular Events Among Those Not Classified Into Statin Benefit Groups.Authors: Melander O, Shiffman D, Caulfield MP, Louie JZ, Rowland CM, Devlin JJ, Krauss RM.
J Am Coll Cardiol. 2015;65:2571-3.
Cost Effectiveness of Sequencing 34 Cancer-Associated Genes as an Aid for Treatment Selection in Patients with Metastatic Melanoma.Authors: Li Y, Bare LA, Bender RA, Sninsky JJ, Wilson LS, Devlin JJ, Waldman FM
Mol Diagn Ther. 2015;19:169-77